no Phase II or III trials published Most common AOD-9604 side effect / Injection-site reaction (redness, swelling) Most common reported MOTS-c side effect / Transient flushing and mild GI discomfort (anecdotal, not trial-confirmed) Growth hormone axis impact / AOD-9604 does not activate the GH receptor
Some patients need these injections almost daily, while others will be prescribed the injections once every three months or so, and others may only need a top-up once a year, this all depends on your progress, where you are within your weight loss journey, and how much you are looking to lose
confident statements are premature
The results showed statistically significant but clinically modest weight loss (2kg average advantage over placebo at the 1mg oral dose over 23 weeks)
Confirm current approval information through FDA.gov and current study listings through ClinicalTrials.gov
More water means a lower concentration and a larger draw volume for the same research quantity